PROSPECTIVE MONITORING OF AIRWAY COLONIZATION AS WAY TO VENTILATOR-ASSOCIATED PNEUMONIA PROPHYLAXIS


Cite item

Full Text

Abstract

Introduction. Ventilator-associated pneumonia is the most common type of nosocomial infection. It’s characterized high mortality (24-76%), leads to increase of mechanical ventilation length, length of stay in intensive care units, significant increase of hospital length of stay and cost of care. The aim of this study was to perform the systematic analysis of the current literature devoted to the problem of airway bacterial colonization and ventilator-associated pneumonia (VAP) prophylaxis. Objectives of the study: the definition of the value of airway bacterial colonization in clinical practice, feasibility of airway bacterial colonization monitoring, prophylaxis, VAP diagnosis and prophylaxis which based on the bacterial colonization monitoring data. For the solution of the designated objectives in the scientific medical databases Medscape and Pubmed there was performed the search for the publications on subject headings, covering these problems. Conclusion. Airway bacterial colonization by potential infectious agent is a one of the key stage in VAP development. Prospective bacterial colonization monitoring (in addition to laboratory and instrumental analysis, clinical presentation) enable to get current microbiological data in prospective mode and to provide the targeted real-time antibacterial therapy in case of pneumonia onset. But at present this way is not convential and requires additional improvement. The guidelines to selection of time, type, technology and personalization VAP prophylaxis methods can be developed on basis of this technique.

About the authors

Vladimir Aleksandrovich Sinikin

Russian Medical Academy of Postgraduate Education Studies

Email: sabaot@mail.ru
postgraduate student of Infection Disease department 2/1, Barrikadnaya Str., Moscow, Russian Federation, 125993

V. B Beloborodov

Russian Medical Academy of Postgraduate Education Studies

Email: vb_beloborodov@mail.ru
доктор мед. наук, проф. каф. инфекционных болезней ФГБОУ ДПО РМАНПО Минздрава России 2/1, Barrikadnaya Str., Moscow, Russian Federation, 125993

References

  1. Chastre J., Fagon J.Y. Ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 2002; 165: 867-903.
  2. Rello J., Ollendorf D.A., Oster G., Vera-Llonch M., Bellm L., Redman R. et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002; 122 (6): 2115-21.
  3. Spalding M.C., Cripps M.W., Minshall C.T. Ventilator-Associated Pneumonia: New Definitions. Crit. Care Clin. 2017; 33 (2): 277-92.
  4. Kollef M.H., Chastre J., Fagon J.Y. et al. Global prospective epidemiologic and surveillance study of ventilator-associated pneumonia due to Pseudomonas aeruginosa. Crit. Care Med. 2014; 42 (10): 2178-87.
  5. Rello J., Jubert P., Vallés J., Artigas A., Rué M., Niederman M.S. Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clin. Infect. Dis. 1996; 23 (5): 973-8.
  6. Berthelot P., Grattard F., Mahul P. et al. Prospective study of nosocomial colonization and infection due to Pseudomonas aeruginosa in mechanically ventilated patients. Intensive Care Med. 2001; 27 (3): 503-12.
  7. Cook D.J., Walter S.D., Cook R.J., Griffith L.E., Guyatt G.H., Leasa D. et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann. Intern. Med. 1998; 129 (6): 433-40.
  8. Choudhuri A.H. Ventilator-Associated Pneumonia: When to hold the breath? Int. J. Crit. Illn. Inj. Sci. 2013; 3: 169-74.
  9. Zimlichman E., Henderson D., Tamir O., Franz C., Song P., Yamin C.K. et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern. Med. 2013; 173 (22): 2039-46.
  10. Safdar N., Dezfulian C., Collard H.R., Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit. Care Med. 2005; 33 (10): 2184-93.
  11. Bouadma L., Sonneville R., Garrouste-Orgeas M. et al. OUTCOMEREA Study Group Ventilator-associated events: prevalence, outcome, and relationship with ventilator-associated pneumonia. Crit. Care Med. 2015; 43 (9): 1798-806.
  12. Dick A.W., Perencevich E.N., Pogorzelska-Maziarz M., Zwanziger J., Larson E.L., Stone P.W. A decade of investment in infection prevention: a cost-effectiveness analysis. Am. J. Infect. Control. 2015; 43 (1): 4-9.
  13. Tumbarello M., De Pascale G., Trecarichi E.M. et al. Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients. Intensive Care Med. 2013; 39 (4): 682-92.
  14. Adair C.G., Gorman S.P., Feron B.M., Byers L.M., Jones D.S., Goldsmith C.E. et al. Implications of endotracheal tube biofilm for ventilator-associated pneumonia. Intensive Care Med. 1999; 25 (10): 1072-6.
  15. Berton D.C., Kalil A.C., Teixeira P.J. Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia. Cochrane Database Syst. Rev. 2014; 10: 15.
  16. Kalil A.C., Metersky M.L., Klompas M. et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin. Infect. Dis. 2016; 63: 13.
  17. Hilty M., Burke C., Pedro H., Cardenas P., Bush A. et al. Disordered microbial communities in asthmatic airways. PLOS One. 2010; 5: e8578.
  18. Dickson R.P., Martinez F.J., Huffnagle G.B. The role of the microbiome in exacerbations of chronic lung diseases. Lancet. 2014; 384: 691-702.
  19. Dickson R.P., Huffnagle G.B. The lung microbiome: new principles for respiratory bacteriology in health and disease. PLoS Pathog. 2015; 11: e1004923.
  20. Dickson R.P., Erb-Downward J.R., Freeman C.M., McCloskey L., Beck J.M. et al. Spatial variation in the healthy human lung microbiome and the adapted island model of lung biogeography. Ann. Am. Thorac. Soc. 2015; 12: 821-30.
  21. Craven D.E., Kunches L.M., Kilinsky V., Lichtenberg D.A., Make B.J., McCabe W.R. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am. Rev. Respir. Dis. 1986; 133 (5): 792-6.
  22. Winterbauer R.H., Durning RB Jr, Barron E., McFadden M.C. Aspirated nasogastric feeding solution detected by glucose strips. Ann. Intern. Med. 1981; 95 (1): 67-8.
  23. Holzapfel L., Chevret S., Madinier G., Ohen F., Demingeon G., Coupry A., Chaudet M. Influence of long-term oro- or nasotracheal intubation on nosocomial maxillary sinusitis and pneumonia: results of a prospective, randomized, clinical trial. Crit. Care Med. 1993; 21: 1132-8.
  24. de Smet A.M., Kluytmans J.A., Cooper B.S. et al. Decontamination of the digestive tract and oropharynx in ICU patients. N. Engl. J. Med. 2009; 360 (1): 20-31.
  25. Daneman N., Sarwar S., Fowler R.A. et al. Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis. Lancet Infect. Dis. 2013; 13 (4): 328-41.
  26. Kollef M.H., Afessa B., Anzueto A. et al. NASCENT Investigation Group. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. J.A.M.A. 2008; 300 (7): 805-13.
  27. Bowton D.L., Hite R.D., Martin R.S. The impact of hospital-wide use of a tapered cuff endotracheal tube on VAP incidence. Respir. Care. 2013; 58 (10): 1582-7.
  28. Bouza E., Perez M.J., Munoz P. et al. Continuous aspiration of subglottic secretions in the prevention of ventilator-associated pneumonia in the post-operative period of major heart surgery. Chest. 2008; 134: 938-46.
  29. Lacherade J.C., De Jonghe B., Guezennec P. et al. Intermittent subglottic secretion drainage and ventilator-associated pneumonia: a multicenter trial. Am. J. Respir. Crit. Care Med. 2010; 182: 910-7.
  30. O’Horo J., Lan H., Thongprayoon C., Schenck L., Ahmed A., Dziadzko M. “Bundle” Practices and Ventilator-Associated Events: Not Enough. Infection Control & Hospital Epidemiology. 2016; 37 (12): 1453-7.
  31. Eom J.S., Lee M.S., Chun H.K., Choi H.J., Jung S.Y., Kim Y.S. et al. The impact of a ventilator bundle on preventing ventilator-associated pneumonia: A multicenter study. Am. J. Infect. Control. 2014; 42 (1): 34-7.
  32. Greenfield S., Teres D., Bushnell L.S. et al. Prevention of Gram-negative bacillary pneumonia using aerosol polymyxin as prophylaxis. I. Effect on the colonization pattern of the upper respiratory tract of seriously ill patients. J. Clin. Invest. 1973; 52: 2935-40.
  33. Klick J.M., du Moulin G.C., Hedley-Whyte J. et al. Prevention of Gram-negative bacillary pneumonia using polymyxin aerosol as prophylaxis. II. Effect on the incidence of pneumonia in seriously ill patients. J. Clin. Invest. 1975; 55: 514-9.
  34. Rouby J.J., Poète P., Martin de Lassale E. et al. Prevention of gram negative nosocomial bronchopneumonia by intratracheal colistin in critically ill patients. Histologic and bacteriologic study. Intensive Care Med. 1994; 20: 187-92.
  35. Falagas M.E., Siempos I.I., Bliziotis I.A. et al. Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials. Crit. Care. 2006; 10: R123.
  36. Karvouniaris M.M.D., Zygoulis P., Triantaris A. et al. Nebulized colistin for ventilator-associated pneumonia prevention. Eur. Respir. J. 2015; 46: 1732-9.
  37. Valles J., Peredo R., Burgueno M.J., Rodrigues de Freitas A.P., Millan S. et al. Efficacy of single-dose antibiotic against early-onset pneumonia in comatose patients who are ventilated. Chest. 2013; 143: 1219-25.
  38. Tagami T., Matsui H., Fushimi K., Yasunaga H. Prophylactic antibiotics may improve outcome in patients with severe burns requiring mechanical ventilation: Propensity score analysis of a Japanese nationwide database. Clin. Infect. Dis. 2016; 62 (1): 60-6.

Copyright (c) 2017 Eco-vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies